- AiHuiShou International (RERE)
- Century Therapeutics (IPSC)
- ATAI Life Sciences (ATAI)
- Jaws Juggernaut Acquisition (JUGGU)
- Tremor International (TRMR)
- Ambrx Biopharma (AMAM)
- Cyteir Therapeutics (CYT)
- Codex DNA (DNAY)
- Femasys (FEMY)
Credit Suisse Maintains Neutral on Walgreens Boots Alliance, Lowers Price Target to $48
Credit Suisse analyst A.J. Rice maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Neutral and lowers the price target from $50 to $48.